Sponsor Dossier
Astellas Pharma
Sponsor Dossier for Astellas Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADVAGRAF XL
- Brand: BETMIGA
- Brand: FLOMAXTRA
- Brand: IZERVAY
- Brand: PADCEV
- Brand: PROGRAF
- Brand: PROGRAF-XL
- Brand: VEOZA
- Device (sponsor): Surgical procedure kit, ophthalmic, medicated, single-use
About
Astellas Pharma is an Australian Private Company with ABN 81147915482, registered in New South Wales. The entity is currently Active.
Portfolio
Astellas Pharma has 12 brands on the ARTG, of which 11 are indexable. Eleven brands have Product Information on file, and 5 brands are PBS-listed. Nine brands have PBAC outcomes on record and 4 brands have AusPARs on record.
Therapeutic focus
— Oncology: 4 brands — Immunology: 3 brands — Urology: 3 brands — Ophthalmology: 1 brand — Women's Health: 1 brand
PBS footprint
Five of Astellas Pharma's brands are PBS-listed, with the portfolio's latest schedule date being 1 May 2026.
Regulatory activity
The most recent PBAC outcome in the portfolio is dated 1 November 2025, with 9 brands having PBAC outcomes on record. The most recent AusPAR is dated 30 June 2022, with 4 brands having AusPARs on record.